CTRI/2022/12/048622招募中未知
Dapagliflozin add-on to metformin in type 2 diabetes mellitus those who are inadequatively controlled on a stable dose of metformin- In Shahjahanpur district population
Aditya kumar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with T2DM inadequately controlled with Metformin 1-2 gm per day
- •2. Those patients who are unable to tolerate further increase in further dose of Metformin
- •3. Patients aged 30 to 70 years
- •4. HbA1C 7.0% to 9.0%
排除标准
- •1. Patient who are on insulin
- •2. Patient described any other anti diabetic medication after adding Dapagliflozin to Metformin
- •3. Patients in which dose of metformin has to be altered
- •4. Patients with renal insufficiency (GFR lress than 30ml/min/1.73m2)
- •5. Patients who are known case of urinary tract infection , structural abnormalities of urinary tract.
- •6. Patients with acute complications of diabetes mellitus
- •7. Patients with hypersensitivity to drug
研究者
相似试验
已完成
3 期
Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlType 2 DiabetesNCT04356742Dong-A ST Co., Ltd.198
尚未招募
3 期
A study on the effect of Dapagliflozin and Metformin combination on Insulin resistance and cardiovascular disease risk factors in subjects with type II diabetes mellitusCTRI/2023/10/059034S Abissha
招募中
2 期
A single-site study of the effectiveness of Dapagliflozin for diabetic patients admitted to the intensive care unitMetabolic and Endocrine - DiabetesDiabetesACTRN12621001102864Austin Health40
尚未招募
不适用
Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liverJPRN-UMIN000026549Kagawa prefectural central hospital25
尚未招募
4 期
Comparative effects of dapagliflozin and metformin in obese diabetic patientsCTRI/2023/11/059814Shobana